Skip to main content

Agenus Inc

AGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001098972

No open-market purchases or sales by Agenus Inc insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $43.6M in total; no superinvestor holds it.

Superinvestors holding AGEN, Q2 2026

See all superinvestors

No superinvestor reported holding AGEN in Q2 2026.